Difference between revisions of "Team:IISc Bangalore"

Line 137: Line 137:
 
<div class="content-middle wthree">
 
<div class="content-middle wthree">
 
<div class="container" id="refer">
 
<div class="container" id="refer">
−
<!-- <div class="mid-content fadeInRight wow  animated" data-wow-delay=".5s">
+
<div class="mid-content fadeInRight wow  animated" data-wow-delay=".5s">
−
<h3>The purpose</h3>
+
<h3>Overview</h3>
−
</div> -->
+
</div>  
 +
<p>of Our Project</p>
 
<div class="row">
 
<div class="row">
 
<div class="refer col-md-6">
 
<div class="refer col-md-6">
 +
<p class="whitef">With the advent of rDNA technology in the late 1970s, medicine, agriculture and several other areas underwent a quantum leap and from that point, progress only hastened, from one only one recombinant pharmaceutical  approved for human use (insulin) in 1982 to one hundred and fifty-one FDA approved protein based recombinant pharmaceuticals by 2009<a href="#refer" onclick="closeTab()">[1]</a>.
 +
<br><a href="https://2016.igem.org/Team:IISc_Bangalore/Description"><span class="readm hvr-ripple-out">Read more</span></a>
 +
</p>
 
</div>
 
</div>
 
</div>
 
</div>
Line 147: Line 151:
 
</div>
 
</div>
 
<!--content-middle-->
 
<!--content-middle-->
−
<b>Overview of Our Project</b>
+
<!--content-middle-->
−
<p class="whitef">With the advent of rDNA technology in the late 1970s, medicine, agriculture and several other areas underwent a quantum leap and from that point, progress only hastened, from one only one recombinant pharmaceutical  approved for human use (insulin) in 1982 to one hundred and fifty-one FDA approved protein based recombinant pharmaceuticals by 2009<a href="#refer" onclick="closeTab()">[1]</a>.
+
<div class="content-middle wthree">
−
<br><a href="https://2016.igem.org/Team:IISc_Bangalore/Description"><span class="readm hvr-ripple-out">Read more</span></a>
+
<div class="container" id="refer">
−
</p>
+
<div class="mid-content fadeInRight wow  animated" data-wow-delay=".5s">
−
<b>Our Bioreactor Design</b>
+
<h3>Our Bioreactor Design</h3>
 +
</div>  
 +
<p>of Our Project</p>
 +
<div class="row">
 +
<div class="refer col-md-6">
 
<p class="whitef leftMove">We realized that manufacturing units use expensive and energy expensive machinery <a href="#refer" onclick="closeTab()">[3]</a>. Hence, we engineered our bacteria in such a way that it could do most of the work done by these monstrous machines so that we no longer have to buy them and pay their bills.
 
<p class="whitef leftMove">We realized that manufacturing units use expensive and energy expensive machinery <a href="#refer" onclick="closeTab()">[3]</a>. Hence, we engineered our bacteria in such a way that it could do most of the work done by these monstrous machines so that we no longer have to buy them and pay their bills.
 
<br><a href="https://2016.igem.org/Team:IISc_Bangalore/Description"><span class="readm hvr-ripple-out">Read more</span></a>
 
<br><a href="https://2016.igem.org/Team:IISc_Bangalore/Description"><span class="readm hvr-ripple-out">Read more</span></a>
 
</p>
 
</p>
 +
</div>
 +
</div>
 +
</div>
 +
</div>
 +
<!--content-middle-->
 +
 +
 +
 +
  
 
<br><br>
 
<br><br>

Revision as of 21:03, 19 October 2016



Team IISc iGem



Overview

of Our Project

With the advent of rDNA technology in the late 1970s, medicine, agriculture and several other areas underwent a quantum leap and from that point, progress only hastened, from one only one recombinant pharmaceutical approved for human use (insulin) in 1982 to one hundred and fifty-one FDA approved protein based recombinant pharmaceuticals by 2009[1].
Read more

Our Bioreactor Design

of Our Project

We realized that manufacturing units use expensive and energy expensive machinery [3]. Hence, we engineered our bacteria in such a way that it could do most of the work done by these monstrous machines so that we no longer have to buy them and pay their bills.
Read more